Clinical Trial Update: Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis [Phase 2]

View source ↗

Summary

This document reports an ongoing Phase 2 trial evaluating the safety and efficacy of Pegolsihematide for treating anemia in participants on dialysis, with the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Pegolsihematide

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Chronic Renal Failure, Anemia | Phase 2 | Status: UNKNOWN